Skip to content
Dose Brief
Menu

MadeMed review

By Updated

MadeMed publishes quarterly and six-month prices for injectable and sublingual treatment; the full term is prepaid, and supply timing needs confirmation.

Brief Score86/100Grade BNo. 21 in our directory
Visit MadeMed View the provider’s current plans and terms.
Semaglutide

$239/mo injectable

Quarterly prepay: $717 upfront; no monthly plan.

Sublingual: $219/mo, $657 upfront quarterly. Six-month options cost less.

Full price details

$239/mo injectable and $219/mo sublingual on the quarterly plan ($717 / $657 in one charge); $199 and $179 on the 6-month plan. No month-to-month option

Tirzepatide

$399/mo injectable

Quarterly prepay: $1,197 upfront; no monthly plan.

Sublingual: $299/mo, $897 upfront quarterly. Six-month options cost less.

Full price details

$399/mo injectable and $299/mo sublingual on the quarterly plan ($1,197 / $897 in one charge); $369 and $279 on the 6-month plan. No month-to-month option

Coverage
Availability varies by treatment and state; confirm the selected product before prepaying
Brand-name
Not confirmed

Prices checked against MadeMed's published terms in . Providers change pricing without notice — check the current figure before you buy.

On the trackerStableprice stable— Each treatment route has a published price that stays the same across doses.

MadeMed in depth

MadeMed lists quarterly and six-month plans, with no month-to-month option on the four checked product pages. Injectable semaglutide costs $239 a month on the quarterly plan ($717 per charge) or $199 for six months ($1,194 upfront). Injectable tirzepatide costs $399 quarterly ($1,197 per charge) or $369 for six months ($2,214 upfront). These are monthly equivalents of prepaid charges, not an option to buy a single month.

Every product page leads with the six-month number — "From $199/mo", "From $179/mo", "From $369/mo", "From $279/mo" — so the price quoted anywhere else is the one that requires committing to half a year and paying for it in one charge. By contrast, System Labs sells month-to-month as its only cadence. The quarterly rung runs $20 to $40 a month higher, in exchange for a shorter prepaid term.

The sublingual products have separate prices. Semaglutide is $219 a month quarterly ($657 per charge) or $179 for six months ($1,074 upfront). Tirzepatide is $299 quarterly ($897 per charge) or $279 for six months ($1,674 upfront). Their lower advertised cost does not establish equivalent absorption, effectiveness or FDA approval compared with an approved oral product or an injection.

Within a plan the price does not move with the dose. Injectable semaglutide is $239 a month at 0.25 mg and still $239 at 2.4 mg; injectable tirzepatide is $399 from 2.5 mg through 15 mg; sublingual tirzepatide is $299 from 3 mg through 7 mg. That is a genuine advantage if you intend to titrate up to a full dose, because the entire schedule can be costed before you start. It is a genuine disadvantage if you plan to sit at a starting dose or microdose, because you pay the full-dose rate the whole time.

Payment and delivery follow different schedules. The checked product pages describe medication shipments on a two-month rhythm while billing every three or six months. Some oral-page copy also refers to a 30-day supply, so the exact quantity and days supplied should be confirmed in writing. Do not infer the supply delivered from the billing period alone.

If a prescription does not come through, the refund is not complete: MadeMed keeps a $39 doctor visit fee. It is a small amount against a $717 charge, but it is a real cost of finding out whether you qualify, and it is the kind of line that usually only appears at checkout.

Availability depends on the product and state. The earlier review recorded different footprints for oral and injectable treatment; this pricing recheck does not establish that every route is available in the same states. Confirm your state, product, prescription quantity and dispensing pharmacy before prepaying.

The four reviewed GLP-1 products are compounded; their prices should not be compared as though they were the same products as approved branded medication. The quarterly charges range from $657 to $1,197 and the six-month charges from $1,074 to $2,214. This fits a buyer comfortable with prepayment after a clinical decision, but offers no single-month trial plan on the checked pages.

Sources we checked

Public program pages and terms, checked October 2026. We have not enrolled in treatment or independently tested the medication.

This source update covers the review text and stated program terms. The existing numerical score has not been recalculated from this check; it should not be read as a new validation of every score factor.

The scorecard

MadeMed scored on our six Brief Score factors. See the methodology.

Price Stability92/100
Supply Reliability84/100
Transparency94/100
Access Breadth76/100
Clinical Oversight84/100
Track Record82/100

What we like

  • Quarterly and six-month charges are published for all four reviewed GLP-1 products
  • Consultation and shipping are included in the checked plans
  • Both injectable and sublingual formats are listed, with separate prices

The caveats

  • At least three months of cost is paid upfront; no monthly plan on the checked pages
  • Billing period and shipment cadence differ, with conflicting supply wording on oral pages
  • Availability varies by product and state; confirm eligibility before paying
  • Compounded sublingual forms are not FDA-approved oral GLP-1 products

The brief

Best for: People comfortable prepaying at least three months who want to compare the exact charge for their prescribed route. MadeMed publishes quarterly and six-month prices for injectable and sublingual treatment; the full term is prepaid, and supply timing needs confirmation.

Ranked #21 of 546 providers we reviewed — compare with CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about MadeMed.

Closest here

The providers scoring nearest MadeMed — read each current assessment before choosing care.

Weighing MadeMed against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs MadeMed, and every provider that outranks it is listed on the MadeMed alternatives ranking.

Other head-to-head comparisons for MadeMed include CoreAge Rx.

More providers we track (24)

514 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect MadeMed's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on MadeMed's site. Not medical advice; see our disclosure.

← Back to all rankings